GLP-1 drugs, MAHA movement increase chicken demand

The convergence of anti-obesity medications and evolving food policy could significantly boost protein consumption in 2025, creating new opportunities for broiler producers, according to Nick Fereday, executive director at Rabobank's research department.

At the 2025 Chicken Marketing Summit, Fereday outlined two transformational trends reshaping the U.S. food landscape: the widespread adoption of GLP-1 weight loss drugs and the growing influence of the Make America Healthy Again (MAHA) movement on food policy.

Read More Here